SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea flag South Korea · Delayed Price · Currency is KRW
905.00
-34.00 (-3.62%)
At close: Jul 14, 2025, 3:30 PM KST

SCM Lifescience Revenue

SCM Lifescience had revenue of 573.60M KRW in the quarter ending March 31, 2025, with 152.09% growth. This brings the company's revenue in the last twelve months to 1.17B, up 41.80% year-over-year. In the year 2024, SCM Lifescience had annual revenue of 824.80M with 18.56% growth.

Revenue (ttm)
1.17B
Revenue Growth
+41.80%
P/S Ratio
22.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
26.00B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 824.80M 129.10M 18.56%
Dec 31, 2023 695.70M 299.72M 75.69%
Dec 31, 2022 395.98M -43.28M -9.85%
Dec 31, 2021 439.26M 119.26M 37.27%
Dec 31, 2020 320.01M 151.51M 89.92%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.10T
SK hynix 71.40T
LG Energy Solution 25.76T
Samsung Biologics 4,898.69B
Hyundai Motor Company 178.98T
KB Financial Group 14.93T
Celltrion 3,662.23B
Kia Corporation 109.25T
Revenue Rankings